Malaria cure with sulphadoxine/pyrimethamine combination in 12 semi-immune adults from West-Central Africa with high rates of point mutations in Plasmodium falciparum dhfr and dhps genes

Parasitology Research

Volumn 97, Issue 4, 2005, Pages 287-289

  Berzosa, Pedro J ^a   Puente, Sabino ^b   Benito, Agustìn ^c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c Red de Investigación de Centros de Enfermedades Tropicales RICET Madrid   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR; FOLIC ACID ANTAGONIST;

ADULT; AFRICA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; MALARIA; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AFRICA, CENTRAL; AFRICA, WESTERN; ANIMALS; ANTIMALARIALS; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; EMIGRATION AND IMMIGRATION; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PYRIMETHAMINE; SPAIN; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM;

EID: 26944437471     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-005-1424-5     Document Type: Article

References (16)

1. Basco LK, Ringwald P (2000b) Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. Am J Trop Med Hyg 62:271-276
2. Basco LK, Tahar R, Keundjian A, Ringwald P (2000a) Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria. J Infect Dis 182:624-628
3. Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee R, Campbell CC (1993) Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 167:932-937
4. Brooks DR, Wang P, Read M, Watkins WM, Sims PF, Hyde JE (1994) Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 224(2):397-405
5. Cowman AF, Morry MJ, Biggs BA, Cross GA, Foote SJ (1988) Amino acid changes linked t pyrimethamine resistance in the dihydrofolate reductase-thymidilate synthase gene of Plasmodium falciparum. Proc Nat Acad Sci USA 85:9109-9113
6. Djimde A, Doumbo OK, Steketee RW, Plowe CV (2001) Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 358:890-891
7. Duraisingh MT (1998) Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropterato sintasa genes by PCR y restriction digestion. Jill Curtis and David C.Warhurst. Exp Parasitol 89:1-8
8. Hall TA (1999) Bioedit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucl Acids Symp Ser 41:95-98
9. Hayton K, Ranford-Cartwright LC, Walliker D (2002) Sulfadoxine- pyrimethamine resistance in the rodent malaria parasite Plasmodium chabaudi. Antimicrob Agents Chemother 46:2482-2489
10. Hyde JE (1990) The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. Pharmacol Ther 48:45-59
11. Kublin JG, Witzig RS, Shankar AH, Zurita JQ, Gilman RH, Guarda JA, Cortese JF, Plowe CV (1998) Molecular assays for surveillance of antifolate-resistant malaria. Lancet 351:1629-1630
12. Nzila AM, Mberu EK, Sulo J, Dayo H, Winstanley PA, Sibley CH, Watkins WM (2000a) Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob Agents Chemother 44:991-996
13. Nzila AM, Nduati E, Mberu EK, Hopkins SC, Monks SA, Winstanley PA, Watkins WM (2000b) Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum. J Infect Dis 181:2023-2028
14. Peters W (1987) Chemotherapy and drug resistance, 2nd edn., vol 1. Academic Press, NY, 542p
15. Peterson DS, Milhous WK, Wellems TE (1990) Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci USA 87:3018-3022
16. Rubio JM, Benito A, Berzosa PJ, Roche J, Puente S, Subirats M, Lopez-Velez R, García L, Alvar J (1999) Usefulness of seminested multiplex PCR in surveillance of imported malaria in Spain. J Clin Microbiol 37:3260-3264